Showing results (121-130 of 153) with videos related to

Sort By:
Pageof 16
Oncogene|March 19, 2003
UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PMLHasan Seker, Carlos Rubbi, Steven P Linke, et al.
Circulation|November 9, 2011
Statin use in outpatients with obstructive coronary artery diseaseSuzanne V Arnold, John A Spertus, Fengming Tang, et al.
Haematologica|March 23, 2023
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabineSarit Assouline, Jadwiga Gasiorek, Julie Bergeron, et al.
Molecular and Cellular Biology|December 3, 2003
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesisIvan Topisirovic, Monica L Guzman, Melanie J McConnell, et al.
Behaviour Research and Therapy|March 6, 2022
Do I really have to do my homework? The role of homework compliance in cognitive behavioral therapy for irritable bowel syndromeChristopher D Radziwon, Brian M Quigley, Alison M Vargovich, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: Implications for translationLuciana Coutinho de Oliveira, Laurent Volpon, Amanda K Rahardjo, et al.
Nature Communications|July 12, 2018
A TFEB nuclear export signal integrates amino acid supply and glucose availabilityLinxin Li, Hans J Friedrichsen, Sarah Andrews, et al.
Oncogene|July 17, 2012
RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growthYves Romeo, Julie Moreau, Pierre-Joachim Zindy, et al.
Circulation. Cardiovascular Quality and Outcomes|March 11, 2022
Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE RegistryWilliam B Borden, Jingyan Wang, Philip Jones, et al.
Blood|May 13, 2009
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirinSarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, et al.
Pageof 16